Galectin Therapeutics Inc (GALT)
3.055
+0.22
(+7.57%)
USD |
NASDAQ |
May 15, 15:53
Galectin Therapeutics Cash and Short Term Investments (Quarterly): 25.66M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 25.66M |
| September 30, 2023 | 20.36M |
| June 30, 2023 | 17.97M |
| March 31, 2023 | 17.80M |
| December 31, 2022 | 18.59M |
| September 30, 2022 | 15.83M |
| June 30, 2022 | 24.18M |
| March 31, 2022 | 31.61M |
| December 31, 2021 | 39.65M |
| September 30, 2021 | 36.60M |
| June 30, 2021 | 31.60M |
| March 31, 2021 | 20.76M |
| December 31, 2020 | 27.14M |
| September 30, 2020 | 32.56M |
| June 30, 2020 | 40.77M |
| March 31, 2020 | 43.33M |
| December 31, 2019 | 47.48M |
| September 30, 2019 | 50.34M |
| June 30, 2019 | 52.04M |
| March 31, 2019 | 6.972M |
| December 31, 2018 | 8.253M |
| September 30, 2018 | 10.14M |
| June 30, 2018 | 10.50M |
| March 31, 2018 | 3.988M |
| December 31, 2017 | 3.053M |
| Date | Value |
|---|---|
| September 30, 2017 | 6.958M |
| June 30, 2017 | 9.127M |
| March 31, 2017 | 13.64M |
| December 31, 2016 | 15.36M |
| September 30, 2016 | 16.06M |
| June 30, 2016 | 18.00M |
| March 31, 2016 | 22.36M |
| December 31, 2015 | 25.85M |
| September 30, 2015 | 21.32M |
| June 30, 2015 | 26.36M |
| March 31, 2015 | 29.35M |
| December 31, 2014 | 29.13M |
| September 30, 2014 | 31.20M |
| June 30, 2014 | 34.42M |
| March 31, 2014 | 36.59M |
| December 31, 2013 | 10.49M |
| September 30, 2013 | 9.715M |
| June 30, 2013 | 5.099M |
| March 31, 2013 | 7.018M |
| December 31, 2012 | 9.364M |
| September 30, 2012 | 11.06M |
| June 30, 2012 | 13.13M |
| March 31, 2012 | 15.31M |
| December 31, 2011 | 6.397M |
| September 30, 2011 | 7.944M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
15.83M
Minimum
Sep 2022
52.04M
Maximum
Jun 2019
31.28M
Average
31.60M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 1.059B |
| Viking Therapeutics Inc | 962.98M |
| 89bio Inc | 562.29M |
| Terns Pharmaceuticals Inc | 263.44M |
| Enanta Pharmaceuticals Inc | 300.31M |